4.7 Article

Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Enhancement of Antitumor Properties of rhTRAIL by Affinity Increase toward Its Death Receptors

Carlos R. Reis et al.

BIOCHEMISTRY (2009)

Review Oncology

TRAIL receptor signalling and modulation: Are we on the right TRAIL?

Devalingam Mahalingam et al.

CANCER TREATMENT REVIEWS (2009)

Article Biochemistry & Molecular Biology

DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design

Vicente Tur et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Biochemistry & Molecular Biology

Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways

G. P. McStay et al.

CELL DEATH AND DIFFERENTIATION (2008)

Article Biochemistry & Molecular Biology

Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2

Delphine Merino et al.

MOLECULAR AND CELLULAR BIOLOGY (2006)

Article Multidisciplinary Sciences

Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor

Almer M. van der Sloot et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Multidisciplinary Sciences

Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis

L Clancy et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Multidisciplinary Sciences

Prediction of water and metal binding sites and their affinities by using the Fold-X force field

JWH Schymkowitz et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Biochemistry & Molecular Biology

Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1

M MacFarlane et al.

CELL DEATH AND DIFFERENTIATION (2005)

Review Cell Biology

Following a TRAIL: Update on a ligand and its five receptors

FC Kimberley et al.

CELL RESEARCH (2004)

Review Biochemistry & Molecular Biology

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

A Almasan et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2003)

Review Biochemistry & Molecular Biology

Apo2L/TRAIL and its death and decoy receptors

HN LeBlanc et al.

CELL DEATH AND DIFFERENTIATION (2003)

Article Biochemistry & Molecular Biology

Predicting changes in the stability of proteins and protein complexes: A study of more than 1000 mutations

R Guerois et al.

JOURNAL OF MOLECULAR BIOLOGY (2002)

Article Biochemistry & Molecular Biology

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity

K Ichikawa et al.

NATURE MEDICINE (2001)

Letter Biochemistry & Molecular Biology

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

D Lawrence et al.

NATURE MEDICINE (2001)

Article Biochemistry & Molecular Biology

Temperature-sensitive differential affinity of TRAIL for its receptors - DR5 is the highest affinity receptor

A Truneh et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)

Article Cell Biology

TRAIL receptor-2 signals apoptosis through FADD and caspase-8

JL Bodmer et al.

NATURE CELL BIOLOGY (2000)